The Latest Breaking News from NYSE

Here's a roundup of top developments in the biotech space over the last 24 hours.

Edwards Lifesciences Corp (NYSE:EW) posted a Q1 adjusted EPS of $0.60, compared to $0.54 posted a year ago and beating the consensus of $0.57. Sales increased 10% to $1.34 billion (underlying 13%), beating the consensus of $1.31 billion. Transcatheter aortic valve replacement sales grew to $881 million, up 11%. Globally, the company's…

On CNBC’s "Mad Money Lightning Round," Jim Cramer said stocks, including Tilray Brands, Inc. (NASDAQ: TLRY) are impossible to own until the Fed legalizes cannabis.

  Ryder System (NYSE:R) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:55 AM. Here's what investors need to know about the announcement.

  Dynex Cap (NYSE:DX) reported its Q1 earnings results on Wednesday, April 27, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Dynex Cap reported in-line EPS of $0.44 versus an estimate of $0.44.

  Norfolk Southern (NYSE:NSC) reported its Q1 earnings results on Wednesday, April 27, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Harley-Davidson Inc (NYSE:HOG) reported first-quarter FY22 sales growth of 5% year-on-year to $1.49 billion. Revenue from the Motorcycles and Related Products segment (HDMC) was $1.3 billion, up 6% Y/Y. Harley-Davidson's EPS of $1.45 was in line with the analyst consensus. Revenue from Motorcycles increased 4%, Parts & Accessories rose 11%, Apparel climbed 2%,…

  Hess Midstream (NYSE:HESM) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

 

European Commission (EC) has granted marketing authorization for VYDURA® (rimegepant) for both the acute treatment of migraine with or without aura, and prophylaxis of episodic migraine in adults who have at least four migraine attacks per month.

Reuters Kellogg Sues British Government Over New Sugar Rules